Cancer vaccinations aim at sensitizing the patient`s immune system to recognize tumor-specific antigens de novo or boosting preexisting immune responses with the ultimate goal to induce long-term tumor-specific CD8+ T cell responses [2, 5, 6]. The gene discussed is CD8A; the disease is neoplasm.